RBC survival
Showing 1 - 25 of >10,000
Anemia Trial in Atlanta (Biotin-Labeled Red Blood Cells (RBCs))
Recruiting
- Anemia
- Biotin-Labeled Red Blood Cells (RBCs)
-
Atlanta, GeorgiaEmory University
Jan 26, 2022
Anemia Trial in Washington, Baltimore (Biotin RBC survival)
Completed
- Anemia
- Biotin RBC survival
-
Washington, District of Columbia
- +1 more
Aug 24, 2022
Diabetes, Red Blood Cell Survival Trial in Iowa City (biotin labeled RBCs)
Completed
- Diabetes
- Red Blood Cell Survival
- biotin labeled RBCs
-
Iowa City, IowaUniversity of Iowa
Feb 4, 2022
Red Blood Cell - IMProving trAnsfusions for Chronically
Recruiting
- Sickle Cell Disease
- +2 more
- Red Blood Cell (RBC) Transfusion
-
Oakland, California
- +13 more
Mar 18, 2022
Sickle Cell Disease Trial in Atlanta (Biotin Labeled Red Blood Cells)
Recruiting
- Sickle Cell Disease
- Biotin Labeled Red Blood Cells
-
Atlanta, Georgia
- +2 more
Nov 1, 2021
Massive Transfusion Trial
Not yet recruiting
- Massive Transfusion
- (no location specified)
Aug 28, 2023
Blood Transfusion in Patients With Lung Cancer
Recruiting
- Transfusion-Transmitted Infection
- Blood transfusion
-
Trabzon, TurkeyDepartment of Chest Diseases, Division Of Intensive Care Medicin
Oct 18, 2022
Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)
Active, not recruiting
- Hematological Malignancies
- Magrolimab
- Azacitidine
-
Duarte, California
- +26 more
Dec 7, 2022
Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
- Trilaciclib
- +2 more
- (no location specified)
May 22, 2023
Anemia Trial in Iowa City (biotin labelled RBCs)
Completed
- Anemia
- biotin labelled RBCs
-
Iowa City, IowaUniversity of Iowa
Apr 28, 2021
Iron Deficiency Trial in New York (Iron-dextran, Saline, Blood Donation)
Active, not recruiting
- Iron Deficiency
- Iron-dextran
- +3 more
-
New York, New YorkColumbia University Medical Center
Feb 14, 2022
Controlled Donors After Circulatory Death and Brain
Completed
- Liver Transplant
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +1 more
Jun 25, 2021
Patient Blood Management In CARdiac sUrgical patientS
Completed
- Anemia
- +5 more
- Ferric carboxymaltose
- +2 more
-
Roma, ItalyFPG Fondazione Policlinico Gemelli IRCCS
Jul 2, 2022
Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Biotin label
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Lymph Node Metastasis and Prognosis in Breast Cancer MRI
Recruiting
- Breast Neoplasm Female
- +4 more
- No interventions
-
Dongguan, Guangdong, China
- +4 more
Aug 13, 2019
Acute Myeloid Leukemia (AML) Trial in Worldwide (Placebo, Venetoclax, Cytarabine)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Placebo
- +2 more
-
Tampa, Florida
- +108 more
Jul 15, 2022
MDS Trial in Worldwide (Luspatercept, Placebo)
Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem
Recruiting
- Acute Myeloid Leukemia (AML)
- Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
- gilteritinib
- +3 more
-
Cincinnati, Ohio
- +18 more
Jan 20, 2023
Cardiac Surgery, Cardiopulmonary Bypass Trial (Adjusted Transfusion)
Not yet recruiting
- Cardiac Surgery
- Cardiopulmonary Bypass
- Adjusted Transfusion
- (no location specified)
Feb 21, 2023
Kidney Failure, Chronic Trial in Seoul (Monofer (experimental), control group)
Not yet recruiting
- Kidney Failure, Chronic
- Monofer (experimental)
- control group
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 5, 2023
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022
Mitapivat in Subjects With Sickle Cell Disease
Enrolling by invitation
- Sickle Cell Anemia
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hepatocellular Carcinoma Trial in Guangzhou (Ronvatinib + sindillimab, radiofrequency ablation)
Not yet recruiting
- Hepatocellular Carcinoma
- Ronvatinib + sindillimab
- radiofrequency ablation
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital, Sun Yat-Sen University
Apr 5, 2023
MDS Trial (Decitabine/Cedazuridine, Magrolimab)
Not yet recruiting
- Myelodysplastic Syndromes
- (no location specified)
Apr 18, 2023